healthcnbc - Raskruti.bissnes

healthcnbc

CVS shares are up 45% this year — here's why it may be starting to turn its business around

CVS shares are up 45% this year — here's why it ma...

1 month ago 37

GE Healthcare soars 9% on earnings beat, wise guidance. Here's our new price target

GE Healthcare soars 9% on earnings beat, wise guid...

1 month ago 37

Senate votes to confirm Robert F. Kennedy Jr. as health secretary

Senate votes to confirm Robert F. Kennedy Jr. as h...

1 month ago 32

Prenuvo adds new health tests to flagship full-body scan, raises $120 million in fresh funding

Prenuvo adds new health tests to flagship full-bod...

1 month ago 31

U.S. investors, Big Pharma race to find new medicines in China

U.S. investors, Big Pharma race to find new medici...

1 month ago 34

Healthy Returns: What to know about Trump's NIH funding cuts

Healthy Returns: What to know about Trump's NIH fu...

1 month ago 50

CVS CEO defends pharmacy middlemen, accuses drugmakers of 'monopolistic' practices

CVS CEO defends pharmacy middlemen, accuses drugma...

1 month ago 27

Neuralink competitor Paradromics secures investment from Saudi Arabia's Neom

Neuralink competitor Paradromics secures investmen...

1 month ago 45

Apple launches first major health study in 5 years. Here's how you can opt in

Apple launches first major health study in 5 years...

1 month ago 26

Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short

Biogen beats estimates on cost cuts and new drugs ...

1 month ago 23

CVS shares pop 10% on big earnings beat, even as high medical costs drag down insurance unit

CVS shares pop 10% on big earnings beat, even as h...

1 month ago 26

We're adding to our position in a sliding stock and booking profits in a 2025 winner

We're adding to our position in a sliding stock an...

1 month ago 39

Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma

Trump is unlikely to end Medicare drug price talks...

1 month ago 46

Hims & Hers faces scrutiny from lawmakers over 'misleading' Super Bowl ad

Hims & Hers faces scrutiny from lawmakers over 'mi...

1 month ago 40

Doximity shares pop 30% on revenue beat, rosy guidance

Doximity shares pop 30% on revenue beat, rosy guid...

1 month ago 37

Alphabet's Verily to sell Granular insurance business to Elevance Health

Alphabet's Verily to sell Granular insurance busin...

1 month ago 46

Doximity shares soar 21% after company beats on revenue, raises fiscal-year guidance

Doximity shares soar 21% after company beats on re...

1 month ago 34

Bristol Myers' stock decline in response to weak guidance is a gift to investors

Bristol Myers' stock decline in response to weak g...

1 month ago 37